Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor
Mutations of the truncated cytoplasmic domain of human erythropoietin receptor (EPOR) result in gain-of-function of erythropoietin (EPO) signaling and a dominantly inherited polycythemia, primary familial and congenital polycythemia (PFCP). We interrogated the unexplained transient absence of perina...
Gespeichert in:
Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2016-05, Vol.94 (5), p.597-608 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Mutations of the truncated cytoplasmic domain of human erythropoietin receptor (EPOR) result in gain-of-function of erythropoietin (EPO) signaling and a dominantly inherited polycythemia, primary familial and congenital polycythemia (PFCP). We interrogated the unexplained transient absence of perinatal polycythemia observed in PFCP patients using an animal model of PFCP to examine its erythropoiesis during embryonic, perinatal, and early postnatal periods. In this model, we replaced the murine
EpoR
gene (m
EpoR
) with the wild-type human
EPOR
(wtH
EPOR
) or mutant human
EPOR
gene (mtH
EPOR
) and previously reported that the gain-of-function mtH
EPOR
mice become polycythemic at 3~6 weeks of age, but not at birth, similar to the phenotype of PFCP patients. In contrast, wtH
EPOR
mice had sustained anemia. We report that the mtH
EPOR
fetuses are polycythemic, but their polycythemia is abrogated in the perinatal period and reappears again at 3 weeks after birth. mtH
EPOR
fetuses have a delayed switch from primitive to definitive erythropoiesis, augmented erythropoietin signaling, and prolonged Stat5 phosphorylation while the wtH
EPOR
fetuses are anemic. Our study demonstrates the in vivo effect of excessive EPO/EPOR signaling on developmental erythropoiesis switch and describes that fetal polycythemia in this PFCP model is followed by transient correction of polycythemia in perinatal life associated with low Epo levels and increased exposure of erythrocytes’ phosphatidylserine. We suggest that neocytolysis contributes to the observed perinatal correction of polycythemia in mtH
EPOR
newborns as embryos leaving the hypoxic uterus are exposed to normoxia at birth.
Key message
Human gain-of-function EPOR (mtH
EPOR
) causes fetal polycythemia in knock-in mice.
Wild-type human EPOR causes fetal anemia in knock-in mouse model.
mtH
EPOR
mice have delayed switch from primitive to definitive erythropoiesis.
Polycythemia of mtH
EPOR
mice is transiently corrected in perinatal life.
mtH
EPOR
newborns have low Epo and increased exposure of erythrocytes’ phosphatidylserine. |
---|---|
ISSN: | 0946-2716 1432-1440 |
DOI: | 10.1007/s00109-015-1375-y |